Evidence map›Paper›PMID 25133611›Full record

ArticlePloS one2014

Mst1 directs Myosin IIa partitioning of low and higher affinity integrins during T cell migration.

Xiaolu Xu, Emily R Jaeger, Xinxin Wang, Erica Lagler-Ferrez, Serge Batalov, Nancy L Mathis, Tim Wiltshire, John R Walker, Michael P Cooke, Karsten Sauer and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. β2 Integrins-Multi-Functional Leukocyte Receptors in Health and Disease.International journal of molecular sciences · 2020
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Xiaolu XuDepartment of Pathology and Immunology, Washington University, St. Louis, Missouri, United States of America.
Emily R JaegerDepartment of Pathology and Immunology, Washington University, St. Louis, Missouri, United States of America.
Xinxin WangDepartment of Pathology and Immunology, Washington University, St. Louis, Missouri, United States of America.
Erica Lagler-FerrezGenomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
Serge BatalovGenomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
Nancy L MathisDepartment of Pathology and Immunology, Washington University, St. Louis, Missouri, United States of America.
Tim WiltshireDivision of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States of America.
John R WalkerGenomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
Michael P CookeGenomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
Karsten SauerDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, United States of America.
Yina H HuangDepartment of Pathology and Immunology, Washington University, St. Louis, Missouri, United States of America; Departments of Pathology and Microbiology & Immunology, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, United States of America.
Genomics Institute of the Novartis Research Foundation · USWashington University in St. Louis · USDartmouth College · USScripps Research Institute · USUniversity of North Carolina at Chapel Hill · US

Funding

PIP3-INDEPENDENT REGULATION OF AKT1 ACTIVITY IN T CELLSR01AI089805 · NIAID · WASHINGTON UNIVERSITY · PI HUANG, YINA HSING · 2011 to 2021
$4.2M
Inositol-Trisphosphate Kinase B (ItpkB) in T Cell Development and FunctionR01AI070845 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SAUER, KARSTEN · 2008 to 2012
$3.0M
Mechanisms of Kinase Function and Drug Resistance in CancerR01GM100785 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI CHE, JIANWEI, SAUER, KARSTEN · 2011 to 2014
$1.4M
NIAID NIH HHS AI070845NIAID NIH HHS AI089805NIAID NIH HHS R01 AI070845NIAID NIH HHS R01 AI089805NIGMS NIH HHS GM100785NIGMS NIH HHS R01 GM100785
6 · The paper itself

Abstract

Chemokines promote T cell migration by transmitting signals that induce T cell polarization and integrin activation and adhesion. Mst1 kinase is a key signal mediator required for both of these processes; however, its molecular mechanism remains unclear. Here, we present a mouse model in which Mst1 function is disrupted by a hypomorphic mutation. Microscopic analysis of Mst1-deficient CD4 T cells revealed a necessary role for Mst1 in controlling the localization and activity of Myosin IIa, a molecular motor that moves along actin filaments. Using affinity specific LFA-1 antibodies, we identified a requirement for Myosin IIa-dependent contraction in the precise spatial distribution of low and higher affinity LFA-1 on the membrane of migrating T cells. Mst1 deficiency or Myosin inhibition resulted in multipolar cells, difficulties in uropod detachment and mis-localization of low affinity LFA-1. Thus, Mst1 regulates Myosin IIa dynamics to organize high and low affinity LFA-1 to the anterior and posterior membrane during T cell migration.

Indexed as

AnimalsCell MovementCells, CulturedChemokine CCL19Hepatocyte Growth FactorIntegrinsLymphocyte Function-Associated Antigen-1Mice, Inbred C57BLMutationNonmuscle Myosin Type IIAProto-Oncogene ProteinsT-LymphocytesChemokine CCL19Hepatocyte Growth FactorIntegrinsLymphocyte Function-Associated Antigen-1macrophage stimulating proteinNonmuscle Myosin Type IIAProto-Oncogene Proteins

Identifiers

PMID25133611
PMCPMC4136924
OpenAlexW1987730675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.